GGrantIndex
← Leaderboards

Federico Innocenti

University Of Chicago

$1,985,541
Attributed
$1,985,541
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $663.4K · FY200915
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$1,985,541 · 4

By mechanism

R21$1,337,295 · 3
K07$648,246 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Single Nucleotide Polymorphism

Research focus

Single Nucleotide PolymorphismGenesGeneticVariation (Genetics)AngiogenesisBaseVariantGenotypePatternPharmaceutical PreparationsPredispositionCancer PatientGenome-WidePhase Iii Clinical TrialsRandomizedMolecular GeneticsMalignant NeoplasmsPathway InteractionsBiologicalIn VitroClinical TrialsMolecularCandidate Disease GeneGenome Wide Association Study

Grant awards (14)

A new model for discovering genetic determinants of angiogenesis and the effect o$198,360
R21 · FY2015 · CA · contact PI
A new model for discovering genetic determinants of angiogenesis and the effect o$165,300
R21 · FY2014 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$130,043
K07 · FY2013 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$130,502
K07 · FY2012 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$131,139
K07 · FY2011 · CA · contact PI
Genome-wide SNP genotyping and expression analysis in human livers$193,050
R21 · FY2010 · DK · contact PI
Genome-wide SNP genotyping and expression analysis in human livers$169,065
R21 · FY2010 · DK · contact PI
A comprehensive pharmacogenetic study of sorafenib in renal cell carcinoma patien$161,021
R21 · FY2010 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$108,004
K07 · FY2010 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$21,694
K07 · FY2010 · CA · contact PI
A comprehensive pharmacogenetic study of sorafenib in renal cell carcinoma patien$10,579
R21 · FY2010 · CA · contact PI
Genome-wide SNP genotyping and expression analysis in human livers$234,000
R21 · FY2009 · DK · contact PI
A comprehensive pharmacogenetic study of sorafenib in renal cell carcinoma patien$205,920
R21 · FY2009 · CA · contact PI
Genome-Wide molecular epidemiology of treatment outcome and cancer risk$126,864
K07 · FY2009 · CA · contact PI